The AHA today voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer television advertisements and encouraged the agency to “rein in skyrocketing drug prices” for patients and the providers who serve them. “We appreciate CMS’s focus on this issue, and we believe this proposal represents an important first step in bringing more transparency to drug pricing,” AHA wrote. “Further, the specific provisions outlined in this proposed rule are consistent with drug price solutions for which the AHA will continue to advocate.” In the rule, the agency estimates that U.S. prescription drug spending grew to about $457 billion in 2015, almost 17 percent of overall spending on personal health care services. “These numbers continue to grow at an unsustainable rate far above the rate of inflation,” AHA said. “The public has been clear: more than 80 percent of the American public says that prescription drug costs are ‘unreasonable.’ Despite this outcry, drug manufacturers continue to take advantage of a complicated system to extract high prices.” 

Related News Articles

Headline
In partnership with the AHA and other national health care leaders, the National Quality Forum today launched a task force to identify opportunities to drive…
Headline
In a letter today to Sen. Mark Warner, D-Va., AHA responds to a recent request from the senator for input regarding cybersecurity in the health care sector.
Perspective
Hospitals and health systems are building the future patients want and need to lead their healthiest lives.
Headline
Health care workers who face the complexities of working with big data and population health must remain vigilant to potential public health threats and…
Headline
More than two-thirds of air ambulance transports for patients with private insurance were out-of-network in 2017, putting patients at financial risk for the…
Headline
More than 700 health care leaders came together today in Chicago for the Association for Community Health Improvement's National Conference focused on…